erlotinib hydrochloride has been researched along with pd168393 in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (pd168393) | Trials (pd168393) | Recent Studies (post-2010) (pd168393) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 61 | 0 | 33 |
Protein | Taxonomy | erlotinib hydrochloride (IC50) | pd168393 (IC50) |
---|---|---|---|
Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | 1.0702 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.0143 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0334 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.1543 | |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.073 | |
Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | 0.0011 | |
Tyrosine-protein kinase Blk | Homo sapiens (human) | 5.47 | |
Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | 0.5757 | |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 3.14 | |
Tyrosine-protein kinase BTK | Homo sapiens (human) | 5.83 | |
Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.0047 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, M; Hong, X; Liang, J; Lu, C; Sun, X; Tang, J; Wang, X; Xu, W; Yao, X; Zhong, T | 1 |
1 other study(ies) available for erlotinib hydrochloride and pd168393
Article | Year |
---|---|
The activation of EGFR promotes myocardial tumor necrosis factor-α production and cardiac failure in endotoxemia.
Topics: Animals; Endotoxemia; ErbB Receptors; Erlotinib Hydrochloride; Heart Failure; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Quinazolines; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |